SCHEMBL30705605

SCHEMBL30705605

O=C(O)Cc1cc(C(F)(F)F)nn1C1CCCCO1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
RXRA P19793 1/20 0.47
RXRB P28702 1/20 0.47
RXRG P48443 1/20 0.47
CYP4F2 P78329 3/20 0.35
CYP4A11 Q02928 3/20 0.35
GAA P10253 1/20 0.35
TRPV1 Q8NER1 1/20 0.35
NR3C2 P08235 1/20 0.35
CYP2C9 P11712 1/20 0.34
ATR Q13535 2/20 0.34
KHK P50053 2/20 0.32
PTGS2 P35354 2/20 0.32
PDE8B O95263 1/20 0.32
PTGDR2 Q9Y5Y4 1/20 0.31
RIPK1 Q13546 1/20 0.31
GCK P35557 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31475474 0.81 RXRA (0.49) RXRARXRBRXRGCYP4F2CYP4A11
SCHEMBL8932232 0.79 CYP4F2 (0.44) RXRARXRBRXRGCYP4F2CYP4A11
SCHEMBL30705512 0.79 GAA (0.33) RXRARXRBRXRGGAATRPV1
SCHEMBL30705522 0.77 NR3C2 (0.36) RXRARXRBRXRGCYP4F2CYP4A11
SCHEMBL14726472 0.77 CYP4F2 (0.42) RXRARXRBRXRGCYP4F2CYP4A11
SCHEMBL18758369 0.77 CYP4F2 (0.37) RXRARXRBRXRGCYP4F2CYP4A11
SCHEMBL22604901 0.77 GAA (0.42) RXRARXRBRXRGCYP4F2CYP4A11
SCHEMBL3039870 0.76 CYP4F2 (0.37) RXRARXRBRXRGCYP4F2CYP4A11
SCHEMBL30705669 0.75 RXRA (0.33) RXRARXRBRXRGGAATRPV1
SCHEMBL20516874 0.74 RXRA (0.52) RXRARXRBRXRGCYP4F2CYP4A11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4539844-A2 COMPOUNDS FOR TREATMENT OF A CORONAVIRUS INFECTION Trawsfynydd Therapeutics, Inc. (US) 2025-04-23 EP disclosed
CN-119604290-A Compounds for the treatment of coronavirus infections 特劳斯芬尼德治疗股份有限公司 2025-03-11 CN disclosed
WO-2023245166-A2 COMPOUNDS FOR TREATMENT OF A CORONAVIRUS INFECTION TRAWSFYNYDD THERAPEUTICS, INC. (US) 2023-12-21 WO disclosed